Logo-bi
Original Research

1. Designing multi-epitope based peptide vaccine candidates against SARS-CoV-2 using immunoinformatics approach
Ysrafil Ysrafil* ORCID, Zulfiayu Sapiun ORCID, Indwiani Astuti ORCID, Mohammad Anas Anasiru, Nangsih Sulastri Slamet ORCID, Hartati Hartati ORCID, Fadli Husain, Sukmawati Ahmad Damiti ORCID
BioImpacts. 2022;12(4): 359-370. doi: 10.34172/bi.2022.23769
PMCID: PMC9376164     PMID: 35975206     Scopus ID: 85138027836    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
10
1
5
The two designed and constructed multiepitope vaccine have good characteristics and may have the potential to activate humoral and cellular immune responses against SARS-CoV-2. Further research is worth considering to confirm the findings of this study.
Original Article

2. Mosaic vaccine design targeting mutational spike protein of SARS- CoV-2: An immunoinformatics approach
Ysrafil Ysrafil ORCID, Arlan K. Imran, Prisca Syafriani Wicita, Vyani Kamba, Fihrina Mohamad, Ismail Ismail, Ayyub Harly Nurung, Noviyanty Indjar Gama, Sari Eka Pratiwi, Indwiani Astuti ORCID, Firzan Nainu, Talha Bin Emran
Bioimpacts. 2025;15: 26443 | Published on: 2024 Apr 22. doi: 10.34172/bi.2023.26443
PMCID: PMC11830123     PMID: 39963556    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
0
0
2
Original Article

3. Immunoinformatics design of an mRNA vaccine against classical swine fever virus using conserved E2 protein and NS3 T-lymphocyte epitopes
Edward C. Banico ORCID, Ella Mae Joy S. Sira ORCID, Lauren Emily Fajardo ORCID, Fredmoore L. Orosco* ORCID
Bioimpacts. 2025;15: 30778 | Published on: 2025 Apr 06. doi: 10.34172/bi.30778
Article
PDF
XML
Cited By:

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons